| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 319,1 k € | -19.5% | 396,3 k € | +2.4% | 387,1 k € | +11.5% | 347,1 k € | +13.8% | 305,1 k € | +32.1% | 230,9 k € | +36.3% | 169,4 k € | -39.0% | 277,9 k € | +4.0% | 267,1 k € | +10.6% | 241,5 k € | -5.4% | 255,2 k € | +27.2% | 200,7 k € | +4.1% | 192,7 k € | +10.6% | 174,2 k € | -9.8% | 193,0 k € | +21.4% | 159,0 k € | +8.9% | 146,0 k € | +19.9% | 121,8 k € | |
| EBITDA | 315,5 k € | -19.7% | 392,7 k € | +2.4% | 383,5 k € | +11.5% | 344,0 k € | +14.2% | 301,3 k € | +32.1% | 228,0 k € | +36.9% | 166,5 k € | -39.4% | 274,8 k € | +3.8% | 264,9 k € | +10.5% | 239,6 k € | -5.4% | 253,5 k € | +27.4% | 198,9 k € | +12.3% | 177,1 k € | +10.7% | 159,9 k € | -15.5% | 189,2 k € | +19.7% | 158,1 k € | +9.0% | 145,0 k € | +20.0% | 120,9 k € | |
| Operating profit | 275,9 k € | -18.9% | 340,1 k € | +2.7% | 331,0 k € | +13.3% | 292,1 k € | +17.5% | 248,5 k € | +44.9% | 171,4 k € | +48.4% | 115,5 k € | -45.7% | 212,8 k € | -11.4% | 240,3 k € | +10.7% | 217,0 k € | +1723.2% | 11,9 k € | -71.9% | 42,4 k € | -29.4% | 60,1 k € | -17.5% | 72,9 k € | -39.5% | 120,4 k € | +2.4% | 117,5 k € | +9.3% | 107,6 k € | +15.0% | 93,5 k € | |
| Profit/loss | 197,1 k € | -17.5% | 238,7 k € | +4.2% | 229,0 k € | +15.0% | 199,1 k € | +16.5% | 170,9 k € | +44.1% | 118,6 k € | +69.9% | 69,8 k € | -46.7% | 130,9 k € | -15.4% | 154,7 k € | +16.1% | 133,2 k € | +1358.6% | 9,1 k € | -70.2% | 30,6 k € | -22.8% | 39,7 k € | -24.3% | 52,4 k € | -37.1% | 83,4 k € | +0.5% | 83,0 k € | +17.1% | 70,8 k € | +14.1% | 62,1 k € | |
| Equity | 1,1 M € | +0.3% | 1,1 M € | +15.1% | 922,5 k € | +13.6% | 812,1 k € | -18.7% | 998,4 k € | +48.1% | 674,3 k € | -24.9% | 897,6 k € | +8.4% | 827,8 k € | +18.8% | 697,0 k € | +28.5% | 542,2 k € | +32.6% | 409,0 k € | -7.3% | 441,3 k € | +7.5% | 410,7 k € | -12.8% | 471,0 k € | +11.7% | 421,8 k € | +24.7% | 338,4 k € | +32.5% | 255,4 k € | +36.0% | 187,8 k € | |
| Total assets | 1,4 M € | +4.3% | 1,3 M € | +7.9% | 1,2 M € | -16.6% | 1,5 M € | +16.4% | 1,3 M € | +23.0% | 1,0 M € | -20.2% | 1,3 M € | +38.3% | 945,9 k € | +27.3% | 743,3 k € | +21.5% | 611,8 k € | +2.3% | 598,2 k € | -1.0% | 604,4 k € | +8.3% | 558,3 k € | -8.7% | 611,3 k € | +14.1% | 535,7 k € | +27.7% | 419,3 k € | -6.7% | 449,6 k € | +50.5% | 298,7 k € | |
| Cash | 709,9 k € | +17.4% | 604,8 k € | +31.0% | 461,6 k € | -43.1% | 810,9 k € | +42.3% | 569,9 k € | +266.7% | 155,4 k € | -68.8% | 498,0 k € | +6.1% | 469,4 k € | -21.1% | 595,0 k € | +31.9% | 451,0 k € | +8.6% | 415,3 k € | +47.6% | 281,5 k € | +77.9% | 158,2 k € | -36.1% | 247,6 k € | +12.6% | 219,9 k € | +9.0% | 201,7 k € | -23.3% | 263,1 k € | +81.8% | 144,7 k € | |
| Debts | 309,3 k € | +19.2% | 259,6 k € | -16.3% | 310,0 k € | -51.9% | 645,0 k € | +139.1% | 269,8 k € | -24.8% | 358,6 k € | -5.6% | 379,8 k € | +222.4% | 117,8 k € | +154.3% | 46,3 k € | -33.4% | 69,5 k € | -63.2% | 189,2 k € | +16.0% | 163,0 k € | +11.6% | 146,1 k € | +9.6% | 133,3 k € | +17.1% | 113,8 k € | +40.7% | 80,9 k € | -58.3% | 194,2 k € | +76.2% | 110,2 k € | |
Private limited company · Puurs-Sint-Amands · incorporated on 22/03/2004
Private limited company profitable and well capitalised. Cash position rising (+17.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER HERMAN VAN DER VEKEN is a Private limited company incorporated in 2004. Its main activity is: Other human health activities. Its registered office is in Puurs-Sint-Amands.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette